Table 2b.
Obs Used | Variable | Estimate | P-value | OR (99% CI) | C statistic |
---|---|---|---|---|---|
397 | Age | −0.005 | 0.451 | 0.995 (0.977–1.013) | 0.679 |
397 | Sex (0=Males, 1=Females) | −0.294 | 0.172 | 0.745 (0.428–1.298) | 0.679 |
397 | Race: White | 0.292 | 0.374 | 1.339 (0.575–3.119) | 0.680 |
397 | Non-Hispanic | −0.028 | 0.951 | 0.972 (0.299–3.163) | 0.677 |
362 | Income | 0.011 | 0.899 | 1.011 (0.809–1.264) | 0.676 |
389 | Duration of symptom(yrs) | −0.017 | 0.098 | 0.983 (0.958–1.009) | 0.682 |
397 | Duration of symptom: 0:<2yr,1:>=2yrs | −0.506 | 0.020 | 0.603 (0.345–1.055) | 0.688 |
397 | Pain Severity at Baseline | −0.010 | 0.646 | 0.990 (0.935–1.048) | 0.677 |
396 | CMSI Non-Uro symptoms | −0.054 | 0.001 | 0.947 (0.907–0.990) | 0.694 |
397 | Body Map Sites Non-pelvic (0–42) | −0.055 | 0.002 | 0.946 (0.903–0.991) | 0.693 |
397 | Body Map: Head (y/n) | −0.448 | 0.039 | 0.639 (0.366–1.116) | 0.681 |
377 | PCS (0–100) | 0.033 | 0.005 | 1.033 (1.003–1.065) | 0.695 |
377 | MCS (0–100) | −0.007 | 0.499 | 0.993 (0.966–1.020) | 0.677 |
396 | Fatigue Score (29.4 – 83.2) | −0.035 | 0.008 | 0.966 (0.934–0.999) | 0.688 |
396 | Sleep disturbance(28.9 – 76.5) | −0.035 | 0.006 | 0.965 (0.934–0.998) | 0.694 |
396 | Anger (32.4 – 85.2) | −0.003 | 0.803 | 0.997 (0.966–1.029) | 0.677 |
395 | HADS: Depression (0–21) | 0.003 | 0.902 | 1.003 (0.937–1.074) | 0.678 |
395 | HADS: Anxiety (0–21) | −0.005 | 0.832 | 0.995 (0.936–1.058) | 0.677 |
395 | CSQ: CAT total score (0–36) | −0.011 | 0.394 | 0.989 (0.958–1.022) | 0.677 |
394 | PSS total (0–40) | −0.011 | 0.446 | 0.989 (0.955–1.025) | 0.677 |
359 | SEAR Total Score (0–100) | −0.001 | 0.910 | 0.999 (0.982–1.017) | 0.677 |
384 | % of Visits with Medication Change | −0.012 | 0.054 | 0.988 (0.972–1.004) | 0.681 |
Negative estimates indicate lower likelihood of improvement with higher value of predictor variable.
Bold values indicate significant (p<.01) estimates.